Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer L Sargent

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Immunity|October 11, 2011
Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitisAlon Y Hershko, Ryo Suzuki, Nicolas Charles, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|July 21, 2017
Effects of Time and Storage Conditions on the Chemical and Microbiologic Stability of Diluted Buprenorphine for InjectionJohnathan M DenHerder, Ralph L Reed, Jennifer L Sargent, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 30, 2013
Usage of sphingosine kinase isoforms in mast cells is species and/or cell type determinedSandra E Dillahunt, Jennifer L Sargent, Ryo Suzuki, et al.
The Journal of Investigative Dermatology|October 9, 2009
A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severityJennifer L Sargent, Ausra Milano, Swati Bhattacharyya, et al.
Plos One|September 21, 2011
Egr-1 induces a profibrotic injury/repair gene program associated with systemic sclerosisSwati Bhattacharyya, Jennifer L Sargent, Pan Du, et al.
Plos One|July 24, 2008
Molecular subsets in the gene expression signatures of scleroderma skinAusra Milano, Sarah A Pendergrass, Jennifer L Sargent, et al.
The American Journal of Pathology|January 17, 2012
Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targetsMatthew B Greenblatt, Jennifer L Sargent, Giuseppina Farina, et al.
Nature Medicine|June 18, 2025
Bridging the implementation gap in non-communicable diseasesBente Mikkelsen, Pavel Ursu, Claire Chaumont, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 4, 2009
The role of Ifng in alterations in liver gene expression in a mouse model of fulminant autoimmune hepatitisMichael W Milks, James G Cripps, Heping Lin, et al.
Plos One|January 22, 2015
Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohortsMichael E Johnson, J Matthew Mahoney, Jaclyn Taroni, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Immunity|October 11, 2011
Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitisAlon Y Hershko, Ryo Suzuki, Nicolas Charles, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|July 21, 2017
Effects of Time and Storage Conditions on the Chemical and Microbiologic Stability of Diluted Buprenorphine for InjectionJohnathan M DenHerder, Ralph L Reed, Jennifer L Sargent, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 30, 2013
Usage of sphingosine kinase isoforms in mast cells is species and/or cell type determinedSandra E Dillahunt, Jennifer L Sargent, Ryo Suzuki, et al.
The Journal of Investigative Dermatology|October 9, 2009
A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severityJennifer L Sargent, Ausra Milano, Swati Bhattacharyya, et al.
Plos One|September 21, 2011
Egr-1 induces a profibrotic injury/repair gene program associated with systemic sclerosisSwati Bhattacharyya, Jennifer L Sargent, Pan Du, et al.
Plos One|July 24, 2008
Molecular subsets in the gene expression signatures of scleroderma skinAusra Milano, Sarah A Pendergrass, Jennifer L Sargent, et al.
The American Journal of Pathology|January 17, 2012
Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targetsMatthew B Greenblatt, Jennifer L Sargent, Giuseppina Farina, et al.
Nature Medicine|June 18, 2025
Bridging the implementation gap in non-communicable diseasesBente Mikkelsen, Pavel Ursu, Claire Chaumont, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 4, 2009
The role of Ifng in alterations in liver gene expression in a mouse model of fulminant autoimmune hepatitisMichael W Milks, James G Cripps, Heping Lin, et al.
Plos One|January 22, 2015
Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohortsMichael E Johnson, J Matthew Mahoney, Jaclyn Taroni, et al.
Pageof 4